Search Results

Neurodevelopmental effects of natural and synthetic ligands of estrogen and progesterone receptors in zebrafish eleutheroembryos.

• Authors : Vaillant C; Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France.; Gueguen MM

Subjects: Estradiol Congeners/Estradiol Congeners/Estradiol Congeners/*pharmacology ; Estrogens/Estrogens/Estrogens/*pharmacology ; Nervous System/Nervous System/Nervous System/*drug effects

• Source: General and comparative endocrinology [Gen Comp Endocrinol] 2020 Mar 01; Vol. 288, pp. 113345. Date of Electronic Publication: 2019 Dec 05.Publisher: Academic Press Country of Publication: United States NLM ID: 0370735 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Drospirenone (Slynd) - a new progestin-only oral contraceptive.

Subjects: Androstenes/Androstenes/Androstenes/*therapeutic use ; Contraceptives, Oral, Hormonal/Contraceptives, Oral, Hormonal/Contraceptives, Oral, Hormonal/*therapeutic use ; Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/*therapeutic use

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2020 Feb 10; Vol. 62 (1591), pp. 18-19.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Considerations for the use of progestin-only contraceptives.

• Authors : Freeman S; Nell Hodgson Woodruff School of Nursing at Emory University, Atlanta, Georgia 30322, USA. ; Shulman LP

Subjects: Contraceptive Agents, Female*/Contraceptive Agents, Female*/Contraceptive Agents, Female*/adverse effects ; Contraceptive Agents, Female*/Contraceptive Agents, Female*/Contraceptive Agents, Female*/supply & distribution ; Progesterone Congeners*/Progesterone Congeners*/Progesterone Congeners*/adverse effects

• Source: Journal of the American Academy of Nurse Practitioners [J Am Acad Nurse Pract] 2010 Feb; Vol. 22 (2), pp. 81-91.Publisher: Slack for the American Academy of Nurse Practitioners Country of Publication: United States NLM ID: 8916634 Publication Model: Print Cited

Record details

Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.

• Authors : Trapnell CB; Food and Drug Administration, Rockville, USA. ; Donahue SR

Subjects: Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/*pharmacokinetics ; Estradiol Congeners/Estradiol Congeners/Estradiol Congeners/*pharmacokinetics ; Ethinyl Estradiol/Ethinyl Estradiol/Ethinyl Estradiol/*pharmacokinetics

• Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 1998 Dec; Vol. 64 (6), pp. 597-602.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print Cited Medium: Print ISSN: 0009-9236 (Print)

Record details

Cyclic and individualized administration of gonadotropin-releasing hormone agonists plus progestogens: an alternative protocol for contraception.

• Authors : Chryssikopoulos A; 2nd Department of Obstetrics and Gynecology, Medical School, University of Athens, Areteion Hospital, Greece.; Phocas I

Subjects: Contraception*/Contraception*/Contraception*/methods; Buserelin/Buserelin/Buserelin/*administration & dosage ; Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/*administration & dosage

• Source: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology [Gynecol Endocrinol] 1997 Apr; Vol. 11 (2), pp. 119-26.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8807913 Publication Model: Print Cited Medium: Print ISSN: 0951-3590

Record details

[Depot gestagens].

• Authors : Zahradnik HP

Subjects: Family Planning Services*; Progesterone Congeners/Progesterone Congeners/Progesterone Congeners/*administration & dosage; Clinical Trials as Topic

• Source: Archives of gynecology and obstetrics [Arch Gynecol Obstet] 1995; Vol. 257 (1-4), pp. 536-41.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8710213 Publication Model: Print Cited Medium: Print ISSN: 0932-0067 (Print)

Record details

The new pills: awaiting the next generation of oral contraceptives.

• Authors : Klitsch M

Subjects: Contraceptives, Oral, Combined* ; Progesterone Congeners*/Progesterone Congeners*/Progesterone Congeners*/adverse effects; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/chemically induced

• Source: Family planning perspectives [Fam Plann Perspect] 1992 Sep-Oct; Vol. 24 (5), pp. 226-8.Publisher: Alan Guttmacher Institute Country of Publication: United States NLM ID: 0241370 Publication Model: Print Cited Medium: Print ISSN:

Record details

Studies on ovarian function in users of the progestagen only contraceptive pill.

• Authors : Tayob Y; Guillebaud J; Adams J

Subjects: Anovulation* ; Contraception* ; Contraceptive Agents, Female*

• Source: Journal of obstetrics and gynaecology [J Obstet Gynaecol (Lahore)] 1986 Apr; Vol. 6 Suppl 2, pp. S91-5.Publisher: Country of Publication: India NLM ID: 0376607 Publication Model: Print Cited Medium: Print NLM ISO Abbreviation: J Obstet Gynaecol

Record details

A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.

• Authors : Briggs MH

Subjects: Contraceptives, Oral/Contraceptives, Oral/Contraceptives, Oral/*pharmacology ; Contraceptives, Oral, Combined/Contraceptives, Oral, Combined/Contraceptives, Oral, Combined/*pharmacology ; Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/*pharmacology

• Source: The Journal of reproductive medicine [J Reprod Med] 1983 Jan; Vol. 28 (1 Suppl), pp. 92-9.Publisher: Science Printers and Publishers, Inc Country of Publication: United States NLM ID: 0173343 Publication Model: Print Cited Medium: Print

Record details

Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.

• Authors : Kay CR

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*chemically induced ; Contraceptives, Oral/Contraceptives, Oral/Contraceptives, Oral/*adverse effects ; Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/Contraceptives, Oral, Synthetic/*adverse effects

• Source: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 1982 Mar 15; Vol. 142 (6 Pt 2), pp. 762-5.Publisher: Elsevier Country of Publication: United States NLM ID: 0370476 Publication Model: Print Cited Medium: Print ISSN: 0002-9378 (Print)

Record details